Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) m...See more
Headquarters:
United States of America
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
2001 (24 years)
Address:
null
LOW
spending power
